{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:06:23Z","timestamp":1790809583623,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jbspin.2018.02.009","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T12:22:35Z","timestamp":1523449355000},"page":"519-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"title":["2018 update of French recommendations on the management of postmenopausal osteoporosis"],"prefix":"10.1016","volume":"85","author":[{"given":"Karine","family":"Briot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Blain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Buchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Debiais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marc","family":"Feron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Bernard","family":"Gauvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Guggenbuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Lehr-Drylewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lespessailles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tremollieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Weryha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cortet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2018.02.009_bib0590","first-page":"785","article-title":"Consensus development panel on osteoporosis","volume":"285","author":"NIH","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0595","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM198812293192604","article-title":"Risk factors for falls among elderly persons living in the community","volume":"319","author":"Tinetti","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0600","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1071\/NB10065","article-title":"Prevalence, circumstances and consequences of falls among community-dwelling older people: results of the 2009 NSW Falls Prevention Baseline Survey","volume":"22","author":"Milat","year":"2011","journal-title":"N S W Public Health Bull"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0605","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00198-005-2031-0","article-title":"Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database","volume":"16","author":"Maravic","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0610","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bone.2015.07.009","article-title":"Changes in number and incidence of hip fractures over 12 years in France","volume":"81","author":"Briot","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0615","series-title":"\u00c9valuation de la prise en charge avant et apr\u00e8s hospitalisation pour fracture de fragilit\u00e9 en France \u00e0 partir des dossiers de la SNIIRAM. Congr\u00e8s SFR 2015, communication O.116","author":"Thomas","year":"2015"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0620","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jbmr.2202","article-title":"Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011","volume":"29","author":"Solomon","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0625","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/archinternmed.2011.447","article-title":"Hip fracture and increased short-term but not long-term mortality in healthy older women","volume":"171","author":"LeBlanc","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0630","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00198-012-2225-1","article-title":"Long-term mortality following fractures at different skeletal sites: a population-based cohort study","volume":"24","author":"Melton","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0635","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0640","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2106\/JBJS.G.01529","article-title":"Proximal humeral fracture as a risk factor for subsequent hip fractures","volume":"91","author":"Clinton","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0645","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1210\/jc.2013-3461","article-title":"The impact of nonhip nonvertebral fractures in elderly women and men","volume":"99","author":"Bliuc","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0650","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s001980050172","article-title":"Forearm fractures as predictors of subsequent osteoporotic fractures","volume":"9","author":"Cuddihy","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0655","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0660","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.2008.092775","article-title":"Clinical subsequent fractures cluster in time after first fractures","volume":"68","author":"van Geel","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0665","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/ard.2010.131813","article-title":"Development of a simple prognostic nomogram for individualising 5-year and 10-year absolute risks of fracture: a population-based prospective study among postmenopausal women","volume":"70","author":"van Geel","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0670","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11657-016-0280-5","article-title":"Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data","volume":"11","author":"Bonafede","year":"2016","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0675","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2474-14-121","article-title":"The role of the combination of bone and fall related risk factors on short-term subsequent fracture risk and mortality","volume":"14","author":"Huntjens","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0680","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jbspin.2016.08.002","article-title":"High prevalence of dementia in women with osteoporosis","volume":"84","author":"Amouzougan","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0685","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jbspin.2016.09.022","article-title":"Osteoporosis and ischemic cardiovascular disease","volume":"84","author":"Laroche","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0690","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","article-title":"Prevalent vertebral deformities predict hip fractures and new vertebral deformities but nop wrist fractures","volume":"5","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0695","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0700","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/jbmr.35","article-title":"Manitoba Bone Density Program. Time since prior fracture is a risk modifier for 10-year osteoporotic fractures","volume":"25","author":"Giangregorio","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0705","series-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO technical report series n\u00b0843","first-page":"1","author":"World Health Organization (WHO)","year":"1994"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0710","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1210\/jc.2004-0124","article-title":"Official position of the International Society for Clinical Densitometry","volume":"89","author":"Lewiecki","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0715","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","article-title":"A reference standard for the description of osteoporosis","volume":"42","author":"Kanis","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0720","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00198-010-1336-9","article-title":"International variation in proximal femur bone mineral density","volume":"22","author":"Paggiosi","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0725","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Metanalysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0730","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1359\/jbmr.2003.18.8.1547","article-title":"Fracture prediction from bone mineral density in Japanese men and women","volume":"18","author":"Fujiwara","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0735","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1359\/JBMR.050609","article-title":"Identification of osteopenic women at high risk of fracture: the OFELY study","volume":"20","author":"30Sornay-Rendu","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0740","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1359\/JBMR.050304","article-title":"Predictive value of BMD for hip and other fractures","volume":"20","author":"Johnell","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0745","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.288.15.1898","article-title":"Cummings SR Clinical use of bone densitometry: clinical applications","volume":"288","author":"Bates","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0750","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","article-title":"Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group","volume":"341","author":"Cummings","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0755","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","article-title":"Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study","volume":"34","author":"Schuit","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0760","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","article-title":"Bone mineral density threshold for pharmacological intervention to prevent fractures","volume":"164","author":"Siris","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0765","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1210\/jc.2004-1568","article-title":"Hip fracture in women without osteoporosis","volume":"90","author":"Wainwright","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0770","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes","volume":"305","author":"Schwartz","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0775","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1210\/jc.2011-0076","article-title":"Study of osteoporotic fractures risk factors for nonvertebral fracture in obese older women","volume":"96","author":"Premaor","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0780","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1359\/jbmr.091004","article-title":"Obesity and fractures in postmenopausal women","volume":"25","author":"Premaor","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0785","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1359\/jbmr.081207","article-title":"Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications","volume":"24","author":"Yamamoto","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0790","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy","volume":"386","author":"Gnant","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0795","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(96)01440-7","article-title":"Fall-related factors and risk of hip fracture: the EPIDOS prospective study","volume":"348","author":"Dargent-Molina","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0800","series-title":"British geriatrics Society clinical practice guideline: prevention of falls in older persons","author":"American Geriatrics Society","year":"2010"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0805","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12603-016-0741-y","article-title":"A comprehensive fracture prevention strategy in older adults: the European Union Geriatric Medicine Society (EUGMS) statement","volume":"20","author":"Blain","year":"2016","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0810","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX\u00ae and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0815","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2012.02.014","article-title":"2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis","volume":"79","author":"Briot","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083436","article-title":"FRAX\u00ae: prediction of major osteoporotic fractures in women from the general population: the OPUS study","volume":"8","author":"Briot","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0825","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/jbmr.106","article-title":"The FRAX tool in French women: how well does it describe the real incidence of fracture in the OFELY cohort?","volume":"25","author":"Sornay-Rendu","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0830","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jbmr.12","article-title":"Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women. Sensitivity of the WHO FRAX tool","volume":"25","author":"Tr\u00e9mollieres","year":"2010","journal-title":"Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0835","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00198-011-1883-8","article-title":"FRAX\u00ae probabilities and risk of major osteoporotic fracture in France","volume":"23","author":"Couris","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0840","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00198-011-1824-6","article-title":"Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects?","volume":"5","author":"Bousson","year":"2012","journal-title":"Osteoporoses Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0845","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jbspin.2015.02.005","article-title":"Trabecular bone score: where are we now?","volume":"82","author":"Bousson","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0850","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00198-014-2761-y","article-title":"Lumbar spine texture enhances 10-year fracture probability assessment","volume":"25","author":"Leslie","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0855","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bone.2014.06.034","article-title":"Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program","volume":"67","author":"Leslie","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0860","first-page":"391","article-title":"A meta-analysis of trabecular Bone Score","volume":"22","author":"McCloskey","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bone.2017.05.005","article-title":"Adjusting FRAX on TBS for identification of subjects at high risk of fractures","volume":"101","author":"Couraud","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0865","doi-asserted-by":"crossref","unstructured":"Vasikaran S, Eastell R, Bruy\u00e8re O, et al. Fracture risk prediction and its relationship to FRAX. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 22 391-420.","DOI":"10.1007\/s00198-010-1501-1"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0870","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density. The women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0875","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifEne. Results from a 3 years randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0880","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0885","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0890","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"Meta-analysis of alendronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0895","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0900","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effect of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0905","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0910","article-title":"Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"1","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0915","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1532-5415.2004.52506.x","article-title":"Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of anti-resorptive agents in the old and oldest old","volume":"52","author":"Boonen","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0920","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0925","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid in reducing clinical fracture and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0930","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1532-5415.2009.02673.x","article-title":"Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older","volume":"58","author":"Boonen","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0935","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0940","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0945","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.1997.03540380073035","article-title":"Prevention of non-vertebral fractures by alendronate. A meta-analysis alendronate osteoporosis treatment study groups","volume":"277","author":"Karpf","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0950","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"Clung","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0955","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00198-004-1725-z","article-title":"Metaanalysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women","volume":"16","author":"Papapoulos","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0960","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00198-012-2090-y","article-title":"Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis","volume":"24","author":"Ganda","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0965","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.2106\/JBJS.L.00223","article-title":"Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality","volume":"96","author":"Huntjens","year":"2014","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0970","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jbspin.2014.01.020","article-title":"Usefulness of bone density measurement in fallers","volume":"81","author":"Blain","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0975","article-title":"Interventions for preventing falls in older people living in the community","volume":"9","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0980","article-title":"The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials","volume":"347","author":"El-Khoury","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0985","article-title":"Effectiveness of two year balance training programme on prevention of fall induced injuries in at risk women aged 75\u201385 living in community: oss\u00e9bo randomised controlled trial","volume":"351","author":"El-Khoury","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0990","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i245","article-title":"Effect of structured physical activity on prevention of serious fall injuries in adults aged 70\u201389: randomized clinical trial (LIFE Study)","author":"Gill","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2018.02.009_bib0995","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.39440.525752.BE","article-title":"Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial","volume":"336","author":"Bolland","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1000","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.maturitas.2009.03.006","article-title":"Use of calcium supplementation and the risk of coronary heart disease in 52\u201362-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study","volume":"63","author":"Pentti","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2040","article-title":"Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis","volume":"342","author":"Bolland","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1015","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/ageing\/afu141","article-title":"Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults","volume":"44","author":"Richardson","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128232","article-title":"Opioids contribute to fracture risk: a meta-analysis of 8 cohort studies","volume":"10","author":"Teng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00198-004-1709-z","article-title":"The accuracy of height loss during prospective monitoring for detection of incident vertebral fractures","volume":"16","author":"Siminoski","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00198-005-2017-y","article-title":"The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women","volume":"17","author":"Siminoski","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1040","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1503\/cmaj.090710","article-title":"Accuracy of patient-reported height loss and risk factors for height loss among postmenopausal women","volume":"6","author":"Briot","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1045","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1007\/s00198-017-4116-y","article-title":"Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, 93 Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS)","volume":"28","author":"Modi","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1050","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1359\/jbmr.1999.14.8.1449","article-title":"Individual smallest detectable difference in bone mineral density measurements","volume":"14","author":"Ravaud","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1055","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.1644","article-title":"Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT)","volume":"27","author":"Jacques","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jbmr.1472","article-title":"Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures","volume":"27","author":"Austin","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1065","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jamainternmed.2014.1232","article-title":"Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study","volume":"174","author":"Bauer","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1070","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2014-1971","article-title":"Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment?","volume":"99","author":"Cosman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1075","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00198-015-3179-x","article-title":"Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years","volume":"26","author":"Ferrari","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"A typical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1090","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.1893","article-title":"Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis","volume":"28","author":"Gedmintas","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2010.1098","article-title":"Exposure to oral bisphosphonates and risk of esophageal cancer","volume":"304","author":"Cardwell","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1100","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1105","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis","volume":"75","author":"Mellstr\u00f6m","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1180","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene","volume":"1","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1120","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/jbmr.2442","article-title":"The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT)","volume":"30","author":"Black","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1125","first-page":"30138","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1130","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/archinte.164.18.2024","article-title":"Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis","volume":"164","author":"Lindsay","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1135","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1359\/JBMR.050501","article-title":"Sustained non-vertebral fragility fracture risk reduction after discontinuation of teriparatide treatment","volume":"20","author":"Prince","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1140","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","article-title":"Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial","volume":"386","author":"Leder","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00198-011-1780-1","article-title":"Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women","volume":"23","author":"Freemantle","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1155","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy","volume":"25","author":"Kendler","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bone.2013.10.006","article-title":"Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study","volume":"58","author":"Roux","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1165","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1210\/jc.2016-1801","article-title":"Denosumab or Zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates","volume":"101","author":"Miller","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2018.02.009_bib1170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2007.03.011","article-title":"Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate","volume":"41","author":"McClung","year":"2007","journal-title":"Bone"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18300629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18300629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:23:26Z","timestamp":1761150206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X18300629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":118,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1297319X18300629"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.02.009","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2018 update of French recommendations on the management of postmenopausal osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}]}}